Compare Moderna, Inc. (MRNA) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs United States Natural Gas Fund — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while United States Natural Gas Fund trades at $10.45. The key difference: Moderna, Inc. is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| MRNA | UNG | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Commodities - Energy |
52-Week High | $81.80 | $16.90 |
52-Week Low | $22.36 | $10.15 |
Enterprise Value | $19.70B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.
Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.
UNG trades at $10.29, down 2.09% today, with a bearish technical signal driven by moving averages. The ETF tracks natural gas futures, facing volatility from weather and LNG demand shifts. Recent news highlights comparisons with equity-based natural gas ETFs like FCG, emphasizing UNG's direct exposure to Henry Hub spot prices.
Outlook remains tied to natural gas market dynamics, with risks from storage reports and production levels. Investment appeal hinges on commodity price speculation, but high volatility and lack of traditional fundamentals limit suitability for conservative investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
